DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Autologous Cell Therapy Market 2017-2021" report to their offering.
The global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.
The report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
The latest trend gaining momentum in the market is private funding will fuel market growth. The increasing investments from private enterprises will likely change the market dynamics. Many vendors are investing in production or manufacturing facilities to improve their production or manufacturing expertise. They are also focusing on establishing new business units or companies to penetrate the market further.
According to the report, one of the major drivers for this market is increasing demand for effective drugs for cardiac and degenerative disorders. There has been an increased demand for providing effective drugs for cardiac and degenerative disorders globally. Prior to the advent of autologous cell therapies, there was no effective drug to repair a damaged heart. The discovery of possible cardiac autologous cells opened new possibilities for repairing damaged cardiac tissue caused by acute myocardial infarction or coronary artery disease.
Key vendors
- Brainstorm Cell Therapeutics
- Holostem Advanced Therapies
- Osiris Therapeutics
- Valeant
- Vericel Corporation
Other prominent vendors
- AbbVie
- American CryoStem
- AM-Pharma
- Anterogen
- Apceth Biopharma
- Astellas Pharma
- Athersys
- Baxter International
- Beike Biotechnology
- BIOTIME
- Bluebird bio
- Bristol-Myers Squibb
- Brainxell
-
Others
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Pipeline Landscape
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market Segmentation by therapy
PART 09: Geographical segmentation
PART 10: Decision framework
PART 11: Drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
For more information about this report visit http://www.researchandmarkets.com/research/633cdq/global_autologous
